AU4116500A - The use of alpha lipoic acid in the antimetastatic treatment - Google Patents

The use of alpha lipoic acid in the antimetastatic treatment

Info

Publication number
AU4116500A
AU4116500A AU41165/00A AU4116500A AU4116500A AU 4116500 A AU4116500 A AU 4116500A AU 41165/00 A AU41165/00 A AU 41165/00A AU 4116500 A AU4116500 A AU 4116500A AU 4116500 A AU4116500 A AU 4116500A
Authority
AU
Australia
Prior art keywords
lipoic acid
alpha lipoic
antimetastatic
treatment
antimetastatic treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU41165/00A
Inventor
Ermanno Bernasconi
Walter Cabri
Annamaria Colacci
Monica Vaccari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olon SpA
Original Assignee
Antibioticos SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antibioticos SpA filed Critical Antibioticos SpA
Publication of AU4116500A publication Critical patent/AU4116500A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AU41165/00A 1999-04-09 2000-04-07 The use of alpha lipoic acid in the antimetastatic treatment Abandoned AU4116500A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT1999MI000728A IT1312060B1 (en) 1999-04-09 1999-04-09 USE OF ALPHA LIPOIC ACID IN ANTIMETASTATIC TREATMENT.
ITMI99A0728 1999-04-09
PCT/EP2000/003100 WO2000061143A1 (en) 1999-04-09 2000-04-07 The use of alpha lipoic acid in the antimetastatic treatment

Publications (1)

Publication Number Publication Date
AU4116500A true AU4116500A (en) 2000-11-14

Family

ID=11382641

Family Applications (1)

Application Number Title Priority Date Filing Date
AU41165/00A Abandoned AU4116500A (en) 1999-04-09 2000-04-07 The use of alpha lipoic acid in the antimetastatic treatment

Country Status (4)

Country Link
EP (1) EP1173166A1 (en)
AU (1) AU4116500A (en)
IT (1) IT1312060B1 (en)
WO (1) WO2000061143A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008352076A1 (en) * 2008-03-04 2009-09-11 Robert Rodriguez Modulation of enzymatic structure, activity, and/or expression level
JP2011516473A (en) * 2008-04-04 2011-05-26 ショール，ロバート Pharmaceutical composition
FR2959668B1 (en) * 2010-05-05 2012-07-13 Biorebus PHARMACEUTICAL ASSOCIATION CONTAINING LIPOIC ACID, HYDROXYCITRIC ACID AND SOMATOSTATIN AS ACTIVE INGREDIENTS
WO2011138565A1 (en) * 2010-05-05 2011-11-10 Biorebus Pharmaceutical combination containing lipoic acid, hydroxycitric acid and a somatostatin as active ingredients

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH683920A5 (en) * 1992-12-10 1994-06-15 Marigen Sa New alpha-lipoic acid ester(s) with antitumour and bio-surfactant activity - formulated as spontaneously dispersible concentrate with other surfactants, opt. contg. pharmaceutical or cosmetic active ingredients
HU213677B (en) * 1993-11-09 1997-12-29 Immunal Kft Pharmaceutical compositions for preventing and treating tumor diseases, and process for producing them
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
WO1998036773A1 (en) * 1997-02-20 1998-08-27 Yale University Therapeutic uses for antioxidants
WO1999006040A1 (en) * 1997-08-04 1999-02-11 Berry Christopher J Method of treating disease using a tocotrienol and alpha-lipoic acid or derivatives or an ester thereof
DE69941800D1 (en) * 1998-10-26 2010-01-21 Univ New York State Res Found Salts of lipoic acid derivatives and their use in the treatment of diseases

Also Published As

Publication number Publication date
ITMI990728A1 (en) 2000-10-09
IT1312060B1 (en) 2002-04-04
EP1173166A1 (en) 2002-01-23
WO2000061143A1 (en) 2000-10-19

Similar Documents

Publication Publication Date Title
AUPQ302899A0 (en) Implants for the use in the treatment of aneurysmal disease
HUP0101854A3 (en) The use of fumaric acid derivatives in transplant medicine
GB9915414D0 (en) Medical use
AU4340700A (en) Methods and compositions for use in the treatment of hyperlipidemia
AU3896900A (en) Treatment of pain
AU5547000A (en) Novel treatment
AU3978700A (en) Medical use
AU2021601A (en) Composition for the treatment of dandruff
AU1878201A (en) Composition for the treatment of damaged tissue
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU4116500A (en) The use of alpha lipoic acid in the antimetastatic treatment
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU2566201A (en) Compounds and methods for the treatment of pain
AU3996799A (en) Alpha amino acid composition and method for the treatment of skin
AU3064800A (en) The therapeutic use of r-warfarin as anticoagulant
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU1043601A (en) Medical use
AU1405001A (en) Treatment of diseases
AU4456800A (en) Human hac3
PL350963A1 (en) Use of arylalkanoylpyridazines
AU1581301A (en) Human chemokine beta-13
AU7420800A (en) Medical use
IL143795A0 (en) Use of 3-isoxazolidinones and hydroxylamic acids for the treatment of infections
AU2420201A (en) Compounds and methods for the treatment of pain
AU4475300A (en) Tetrahydroisoquinolinyl-indole derivatives for the treatment of depression

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase